Cancer Research UK logo.
SearchDonate

A trial looking at celecoxib and gemcitabine with or without adenovirus delivered interferon alfa 2b for mesothelioma (INFINITE)

Overview

Cancer types:

Mesothelioma

Status:

Results

Phase:

Phase 3

Details

This trial looked at adenovirus-delivered alfa 2b with celecoxib and gemcitabine. It was for people who had already had treatment for lung mesothelioma. Lung mesothelioma is also called pleural mesothelioma.

People could join the trial between 2019 and 2021. The team presented the results at a conference in 2025.

Recruitment start: 1 August 2019

Recruitment end: 8 April 2021

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Nicola Steele

Supported by

Medpace Inc.

Trizell Ltd.

Last reviewed: 24 Jul 2026

CRUK internal database number: 17041

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Find a Clinical Trial

Search our clinical trials database for all cancer trials and studies recruiting in the UK.

Search
An icon of two speech bubbles, indicating a conversation.

Cancer Chat forum

Connect with other people affected by cancer and share your experiences.

Join
An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.

Talk